Sunday, March 4, 2007

A New Hope for AIDS patients ?


Works When All Other AIDS Drugs Fail,

(as reported in the bulletin of
What follows is a verbatim reportage from the bulletin.

Isentress Works When All Other AIDS Drugs Fail,

Study Shows By Daniel J. DeNoon

WebMD Medical News Reviewed by Louise Chang, MDMarch 1, 2007 --

"Incredibly exciting."
"Road to hope."
"Very exciting."
"A very important milestone in HIV treatment history."

That's what major AIDS researchers are saying about Isentress, the first of a new class of HIV drugs. Early results from two major clinical trials of Isentress were reported this week at the largest annual U.S. HIV conference.

Patients in the studies had run out of treatment options.

After a decade of treatment, the HIV in their bodies had become resistant to at least one drug in each of the three classes of AIDS therapies. Their immune systems had begun to fail and they had high blood levels of HIV.

But when these patients took Isentress in combination with other powerful AIDS drugs, nearly 80% of patients saw their HIV levels plummet to near-undetectable levels after 16 weeks of treatment.

Without Isentress, state-of-the-art treatment helped only 43% of patients to this degree.

Joseph J. Eron Jr., MD, of the University of North Carolina-Chapel

One may register for free medical bulletins at for latest news in the world of medicine.

No comments: